A bacteria testing kit is set to revolutionise the healthcare industry...
Q Technologies Group manufactures the Q Shield family of products which includes hand sanitisers, hard surface sprays and wipes and a Bio fog, which provides an invisible antimicrobial coating to virtually any surface.
Q Shield can be described as the best product of its kind in the world and is recommended by microbiologists and nurses who specialise in infection control across the globe. Alcohol gels are ineffective in comparison with Q Shield, which also helps to reduce the fire risk associated with them as it is non-flammable and non-toxic.
With its latest innovation, the firm also has plans to revolutionise the healthcare industry in the UK and save the NHS between £200 million and £300 million. Q Technologies Group has created Profile One, an inexpensive, portable and easy-to-use kit that significantly reduces the time taken to test for live bacteria to just five minutes. It allows the user to know levels of bacterial contamination on surfaces, in water or in the air in time to deal with them before they become a problem.
You only have to spend a few minutes talking to Chief Executive Andrew Kemp to get an idea of just how passionate he is about marketing this new technology, which is already being used in many forms all over the world.
"We have a huge market for our technology across the Far East and India and especially in Africa, where it is used to protect surfaces from the potential damage that can be caused by microorganisms," said Andrew.
Profile One is now classified as a medical device and is the only product of its kind in the world to achieve this level of regulation. In a healthcare setting it allows a quick and accurate determination of the effectiveness of surface cleaning. Meanwhile, in food production, it can reduce the number of times equipment is removed from the production line and cleaned, only to find no culture growth 24 hours later.
Profile One can significantly reduce the time taken to get a diagnosis, which could help the NHS save time and money as well as unnecessary distress for patients.
“My biggest challenge has not been developing the innovation itself, but trying to secure the funding needed to launch it in the UK,” said Andrew.
“It’s great to be innovative, but you need to have a vehicle that will allow your innovations some presence.
"I've been working on several papers and am currently working with the university in the hope of securing funding to launch Profile One in the UK.”